Market Closed -
Other stock markets
|
After market 03:59:56 pm | |||
27.6 EUR | +4.07% | 27.64 | +0.14% |
Feb. 29 | Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024 | |
Feb. 28 | Pharma Mar, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 509
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology
99.2
%
| 191 | 97.4 % | 157 | 99.2 % | -17.96% |
Diagnostics
0.8
%
| 5 | 2.6 % | 1 | 0.8 % | -76.79% |
RNAi
0.1
%
| 0 | 0.0 % | 0 | 0.1 % | +290.32% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Ireland
47.6
%
| 87 | 44.2 % | 75 | 47.6 % | -13.17% |
France
19.0
%
| 17 | 8.9 % | 30 | 19.0 % | +72.54% |
Other
8.6
%
| 13 | 6.7 % | 14 | 8.6 % | +4.17% |
United States
7.9
%
| 13 | 6.8 % | 13 | 7.9 % | -6.40% |
Rest of the European Union
6.9
%
| 19 | 9.6 % | 11 | 6.9 % | -42.40% |
Spain
4.4
%
| 17 | 8.5 % | 7 | 4.4 % | -58.36% |
Germany
2.9
%
| 15 | 7.6 % | 5 | 2.9 % | -69.05% |
Italy
2.6
%
| 15 | 7.7 % | 4 | 2.6 % | -72.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 86-04-29 | |
Director of Finance/CFO | - | 87-12-31 | |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | - | 02-12-31 | |
Compliance Officer | - | 20-03-31 | |
Ali Zeaiter
CTO | Chief Tech/Sci/R&D Officer | 47 | 17-12-31 |
Chief Tech/Sci/R&D Officer | - | 96-12-31 | |
Nadia Badri
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-31 |
Investor Relations Contact | - | 14-12-31 | |
Sales & Marketing | - | 12-02-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 86-04-29 | |
Director/Board Member | - | 86-04-29 | |
Director/Board Member | - | - | |
Director/Board Member | 79 | - | |
Director/Board Member | 78 | - | |
Director/Board Member | - | 19-06-24 | |
Director/Board Member | - | 22-06-28 | |
Mera Ortega
BRD | Director/Board Member | - | - |
Director/Board Member | - | 22-06-28 | |
Director/Board Member | - | 22-06-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,354,907 | 13,712,564 ( 74.71 %) | 715,000 ( 3.895 %) | 74.71 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
PHARMA MAR, S.A. 3.52% | 652,235 | 3.52% | 20,244,853 $ |
Company contact information
Pharma Mar SA
Avenida de los Reyes, 1 Polígono Industrial La Mina
28770, Colmenar Viejo
+34 91 846 60 00
http://www.pharmamar.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.44% | 498M | |
-2.68% | 85.68B | |
+5.53% | 41.4B | |
-24.99% | 28.22B | |
+54.56% | 24.64B | |
-7.19% | 16.98B | |
-34.20% | 13.29B | |
-17.31% | 11.66B | |
-11.43% | 11.65B | |
-1.57% | 8.18B |
- Stock Market
- Equities
- PHM Stock
- Company Pharma Mar, S.A.